HemeHub

Marcin Wlodarski, MD is an Associate Member in the Department of Hematology and the Experimental Hematology Division at St. Jude Children's Research Hospital in Memphis, Tennessee. He also contributes to the Comprehensive Cancer Center's Hematological Malignancies Program. Marcin Wlodarski, MD earned his MD and PhD from Charité Medical School at Humboldt Universität zu Berlin. His training included internships at the Karolinska Institute in Stockholm and the NHLBI at the National Institutes of Health, followed by pediatric and hematology-oncology specialization at the University Children's Hospital in Freiburg, Germany. A recognized leader in pediatric bone marrow failure and myelodysplastic syndromes (MDS), Marcin Wlodarski, MD focuses on inherited predisposition syndromes such as SAMD9/SAMD9L and GATA2 deficiency. His work integrates patient care with translational research aimed at improving diagnosis and treatment outcomes in children with these conditions. Since joining St. Jude in 2018, Marcin Wlodarski, MD has directed the Bone Marrow Failure Program, advancing both clinical and laboratory research. His efforts have been honored with awards such as the EHA-ASH Training Award in Hematology and the SIOP Young Investigator Award. His recent projects include pioneering studies on somatic genetic rescue using single-cell genomics in pediatric MDS. These investigations, which have been highlighted in leading journals, provide groundbreaking insights into natural gene correction and hold promise for future therapeutic strategies.